Improvement in WHO functional class · pulmonary arterial hypertension
Prostacyclin probably leads to higher improvement in WHO functional class compared with control (moderate certainty).
1 finding from 1 review
Headache+ · pulmonary arterial hypertension
1 finding from 1 review
Six‐minute walk distance · pulmonary arterial hypertension
1 finding from 1 review
All‐cause mortality · pulmonary arterial hypertension
Prostacyclin probably leads to lower mortality compared with control (moderate certainty).
1 finding from 1 review
mPAP (the higher the mPAP, the worse the pulmonary hypertension) · pulmonary arterial hypertension
1 finding from 1 review
PVR · pulmonary arterial hypertension
1 finding from 1 review
Cardiac index · pulmonary arterial hypertension
1 finding from 1 review
RAP · pulmonary arterial hypertension
1 finding from 1 review
Dyspnea · pulmonary arterial hypertension
1 finding from 1 review
Quality of life · pulmonary arterial hypertension
1 finding from 1 review
All‐cause mortality · people with ARDS
It is very uncertain whether aerosolized prostacyclin changes mortality compared with placebo (very low certainty).
1 finding from 1 review
Respiratory effects: PaO2/FiO2 ratio up to 24 hours after initiation of therapy · people with ARDS
1 finding from 1 review
Improvement in mean pulmonary arterial pressure · people with ARDS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events7 · people with ARDS
1 finding from 1 review
Ulcer healing · patients with Buerger's disease
It is very uncertain whether intravenous prostacyclin analogue changes ulcer healing compared with intravenous prostaglandin analogue (very low certainty).
1 finding from 1 review
Complete relief of pain · patients with Buerger's disease
Intravenous prostacyclin analogue showed no clear difference in complete relief of pain compared with intravenous prostaglandin analogue (low certainty).
1 finding from 1 review
Rate of amputation · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Migraine frequency Number of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Duration of attacks · primary Raynaud's phenomenon
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found